To the Editor: There has been amounted evidence of the neuroinvasive potential of the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The main neurological …

To the Editor: There has been amounted evidence of the neuroinvasive potential of the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The main neurological …

Assessment of Guillain-Barre syndrome cases in Brazil in the COVID-19 Era Page 91 91 2.9
Artigo científico 9. Assessment of Guillain-Barre Syndrome Cases in Brazil in the COVID- 19 …

This study reports three cases of Guillain-Barré Syndrome (GBS) associated with SARS-CoV-
2 infection in a tertiary hospital in Manaus, Brazil. The patients exhibited unusual …

Abstract Introduction: Guillain-Barré syndrome (GBS) is a rare peripheral nervous system
inflammatory disease with an annual estimated incidence of 1-2/100 000. Several studies …

Guillain-Barre syndrome (GBS) following a SARS-CoV-2 vaccination has been repeatedly
observed but GBS following a SARS-CoV-2 infection in a vaccinated patient has not been …

OBJECTIVE: To perform a nationwide epidemiological study of Guillain-Barré syndrome
(GBS) in Spain, analysing background incidences and seasonal variation and trying to …

Background The World Health Organization declared the Coronavirus disease (COVID-19)
pandemic on March 11, 2020, which is caused by severe acute respiratory syndrome …

Background and Objectives: Recent findings demonstrate that the transmigration of severe
acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) to the nervous system implicates …

Abstract Single reports of Guillain-Barré syndrome (GBS) have been reported worldwide
during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. While …